Revvity Net Change in Intangible Assets 2010-2025 | RVTY

Revvity annual/quarterly net change in intangible assets history and growth rate from 2010 to 2025. Net change in intangible assets can be defined as the overall change from the sale and purchase of intangible assets including patents, rights and capitalized software.
  • Revvity net change in intangible assets for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • Revvity net change in intangible assets for the twelve months ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • Revvity annual net change in intangible assets for 2024 was $0B, a 0% decline from 2023.
  • Revvity annual net change in intangible assets for 2023 was $0B, a 0% decline from 2022.
  • Revvity annual net change in intangible assets for 2022 was $0B, a 0% decline from 2021.
Revvity Annual Net Change in Intangible Assets
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $N/A
2019 $-5
2018 $N/A
2017 $N/A
2016 $N/A
2015 $N/A
2014 $N/A
2013 $N/A
2012 $N/A
2011 $N/A
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Medical Medical Services $10.993B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $136.013B 25.51
CVS Health (CVS) United States $78.381B 9.74
Elevance Health (ELV) United States $62.395B 8.39
Cencora (COR) United States $56.765B 19.75
DiDi Global (DIDIY) China $26.874B 28.55
Labcorp Holdings (LH) United States $20.399B 16.55
Natera (NTRA) United States $18.966B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.991B 0.00
CochLear (CHEOY) Australia $13.143B 0.00
Solventum (SOLV) United States $12.678B 13.42
ICON (ICLR) Ireland $11.592B 10.78
Viatris (VTRS) United States $10.422B 3.58
Avantor (AVTR) United States $9.056B 13.16
Medpace Holdings (MEDP) United States $8.964B 23.81
Sonic Healthcare (SKHHY) Australia $8.852B 0.00
HealthEquity (HQY) United States $8.449B 37.01
Caris Life Sciences,�Inc (CAI) United States $7.680B 0.00
Charles River Laboratories (CRL) United States $7.587B 14.87
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.918B 28.96
BrightSpring Health Services (BTSG) United States $3.506B 32.17
Sotera Health (SHC) United States $3.139B 17.84
Surgery Partners (SGRY) United States $2.861B 37.20
Concentras Parent (CON) United States $2.507B 14.49
Organon (OGN) United States $2.459B 2.61
Alignment Healthcare (ALHC) United States $2.455B 0.00
GeneDx Holdings (WGS) United States $2.222B 85.57
Progyny (PGNY) United States $1.886B 41.51
PACS (PACS) United States $1.823B 0.00
Premier (PINC) United States $1.725B 13.09
GoodRx Holdings (GDRX) United States $1.672B 33.43
Ardent Health (ARDT) United States $1.589B 6.77
Teladoc Health (TDOC) United States $1.412B 0.00
QDM (QDMI) Hong Kong, SAR China $1.277B 438.00
Establishment Labs Holdings (ESTA) $1.202B 0.00
Pediatrix Medical (MD) United States $1.080B 8.22
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.878B 0.00
AMN Healthcare Services Inc (AMN) United States $0.759B 7.10
CareDx (CDNA) United States $0.663B 10.36
Nutex Health (NUTX) United States $0.632B 9.57
So-Young (SY) China $0.595B 0.00
SBC Medicals (SBC) United States $0.585B 0.00
Embecta (EMBC) United States $0.572B 3.85
InnovAge Holding (INNV) United States $0.531B 0.00
LifeMD (LFMD) United States $0.479B 0.00
Auna S.A (AUNA) Luxembourg $0.470B 10.58
Sonida Senior Living (SNDA) United States $0.466B 0.00
Omada Health (OMDA) $0.453B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.402B 0.00
Enhabit (EHAB) United States $0.342B 28.12
Oncology Institute (TOI) United States $0.312B 0.00
Performant Healthcare (PHLT) United States $0.297B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Pheton Holdings (PTHL) China $0.146B 0.00
DocGo (DCGO) United States $0.146B 23.83
Sera Prognostics (SERA) United States $0.110B 0.00
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
KindlyMD (NAKA) United States $0.066B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
Biodesix (BDSX) United States $0.047B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
ModivCare (MODV) United States $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.043B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.015B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00